Literature DB >> 10089990

Grover's disease: clinicopathologic review of 72 cases.

M D Davis1, A M Dinneen, N Landa, L E Gibson.   

Abstract

OBJECTIVE: To report the clinicopathologic findings in patients with Grover's disease.
MATERIAL AND METHODS: We reviewed the medical records and biopsy specimens from 72 patients with transient acantholytic dermatosis (Grover's disease) examined at Mayo Clinic Rochester. Hematoxylin-eosin-stained biopsy specimens (from all patients) were assessed. Immunohistochemistry stains BRST-2, CAM 5.2, and CD44 were used to stain eight specimens. Direct immunofluorescence reports were reviewed. Selected specimens were stained by indirect immunofluorescence to detect major basic protein.
RESULTS: Of the 72 patients, 63 (88%) were men, and the mean age was 48 years (range, 31 to 85). Lesions were distributed mainly on the trunk (in 71 patients) and proximal extremities (in 25). Heat and sweating frequently were exacerbating factors. Fifteen patients (21%) were bedbound. Concurrent nondermatologic malignant disease was present in 18 patients (25%). Two patients (3%) had acquired immunodeficiency syndrome. Follow-up in 28 patients (mean, 38 months; range, 3 months to 7 years) revealed that the disease had recurred in 13, persisted in 3, and resolved in 12. Review of the biopsy specimens showed that acantholysis was pemphigus vulgaris-like in 40 patients (56%), Darier's disease-like in 16 (22%), spongiotic in 12 (17%), pemphigus foliaceus-like in 2 (3%), and Hailey-Hailey disease-like in 2 (3%). A perivascular lymphocytic infiltrate of varied intensity in 64 specimens (89%) was associated with eosinophils in 16 (22%). In nine biopsy specimens with dermal eosinophilia stained for major basic protein, varied dermal cellular and extracellular deposition of major basic protein was present. Results of direct immunofluorescence studies, performed in 17 cases, were negative or nonspecific. CD44 stained acantholytic areas in addition to sweat glands in two of eight specimens (25%).
CONCLUSION: Further studies of the pathogenesis of Grover's disease are needed. The predisposing conditions, site of involvement, and relapsing nature of this disorder may implicate acrosyringeal dysfunction as the cause.

Entities:  

Mesh:

Year:  1999        PMID: 10089990     DOI: 10.4065/74.3.229

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  9 in total

Review 1.  Chronic pruritus: a paraneoplastic sign.

Authors:  Gil Yosipovitch
Journal:  Dermatol Ther       Date:  2010 Nov-Dec       Impact factor: 2.851

2.  Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.

Authors:  Dan Laheru; Barbara Biedrzycki; Elizabeth M Jaffee
Journal:  Methods Mol Biol       Date:  2013

Review 3.  Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features.

Authors:  Samantha R Ellis; Aren T Vierra; Jillian W Millsop; Mario E Lacouture; Maija Kiuru
Journal:  J Am Acad Dermatol       Date:  2020-04-29       Impact factor: 11.527

Review 4.  Epidermal multinucleated giant cells are not always a histopathologic clue to a herpes virus infection: multinucleated epithelial giant cells in the epidermis of lesional skin biopsies from patients with acantholytic dermatoses can histologically mimic a herpes virus infection.

Authors:  Philip R Cohen; Taraneh Paravar; Robert A Lee
Journal:  Dermatol Pract Concept       Date:  2014-10-31

Review 5.  Acantholytic dyskeratotic acanthoma: case report and review of the literature.

Authors:  Alina Goldenberg; Robert A Lee; Philip R Cohen
Journal:  Dermatol Pract Concept       Date:  2014-07-31

6.  Grover's-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy.

Authors:  Viktor H Koelzer; Tobias Buser; Niels Willi; Sacha I Rothschild; Andreas Wicki; Peter Schiller; Gieri Cathomas; Alfred Zippelius; Kirsten D Mertz
Journal:  J Immunother Cancer       Date:  2016-08-16       Impact factor: 13.751

7.  Grover disease associated with docetaxel chemotherapy.

Authors:  Shawn Afvari; Melvin W Chiu
Journal:  JAAD Case Rep       Date:  2022-09-08

8.  Grover's Disease with Acrosyringeal Acantholysis: A Rare Histological Presentation of an Uncommon Disease.

Authors:  Rajiv Joshi; Atul Taneja
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

9.  A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1.

Authors:  Marc Uemura; Faisal Fa'ak; Cara Haymaker; Natalie McQuail; Elizabeth Sirmans; Courtney W Hudgens; Lydia Barbara; Chantale Bernatchez; Jonathan L Curry; Patrick Hwu; Michael T Tetzlaff; Adi Diab
Journal:  J Immunother Cancer       Date:  2016-09-20       Impact factor: 13.751

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.